Z-2475-2025 Class II Ongoing
FDA device recall Z-2475-2025 was initiated by Diagnostica Stago, Inc. on Jul 21, 2025 and is designated Class II. Reason for recall: Potential for contamination of STA-LIQUID ANTI-Xa by Stago Fibrinogen reagents in UFH and LMWH applications. The recall status is ongoing. Affected quantity: 126,200 units (125,900 US).
Recall details
- Product Type
- Devices
- Report Date
- Sep 3, 2025
- Initiation Date
- Jul 21, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 126,200 units (125,900 US)
Product description
Reason for recall
Distribution pattern
Worldwide - US Nationwide distribution in the states of AL, AZ, CA, CO, FL, GA, LA, MD, ME, MN, MO, MT, NC, OH, OK, OR, PA, PR, SD, VT, WI, WY and the countries of Algeria, Argentina, Austria, Brazil, Bulgaria, Canada, Chile, Colombia, Costa Rica, France, French Polynesie, Guadeloupe, India, Iran, Israel, Jordan, Korea, Kuwait, Lebanon, Malaysia, Mexico, Morocco, Netherlands, Oman, Paraguay, Peru, Republique Tcheque, Romania, Saudi Arabia, Serbia, South Africa, Switzerland, Taiwan, Thailand, Tunisia, Turquie, United Arab Emirates, Uruguay, Vietnam.
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2475-2025
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026